secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2026-06-25T10:18:36+00:00
Accession:  0001213900-26-071721
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MoonLake Immunotherapeutics launches $200M public offering of 9M shares at $20.00 each
--------------------------------------------------------------------------------

- Offering consists of 9,000,000 Class A ordinary shares at $20.00/share plus pre-funded warrants for up to 1,000,000 shares at $19.9999 each.
- Underwriters granted 30-day option to purchase up to 1,500,000 additional shares at the offering price less discounts.
- Gross proceeds expected to be $200 million before underwriting discounts and offering expenses.
- Offering expected to close June 25, 2026; securities sold under effective shelf registration statement (File No. 333-274286).
- Pre-funded warrants exercisable immediately at $0.0001/share, subject to beneficial ownership limitations (4.99% default).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390026071721/0001213900-26-071721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390026071721/ea0295766-8k_moonlake.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-071721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer